VIR BIOTECHNOLOGY INC (VIR) Stock Cash Flow
NASDAQ:VIR - Nasdaq - US92764N1028 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -577.65M | -521.96M | -615.12M | 515.80M | 528.60M | |||
| Depreciation Amortization | 12.91M | 14.56M | 19.45M | 6.80M | 5.80M | |||
| Income Taxes - Deferred | N/A | -2.95M | -1.06M | -15.20M | 15.20M | |||
| Change In Working Capital | 24.20M | -84.01M | -304.59M | 665.40M | -628.40M | |||
| Taxes Paid | N/A | 786.00K | 2.68M | 252.00M | N/A | |||
| Other non cash items | 128.41M | 148.00M | 122.53M | 490.50M | 31.20M | |||
| OPERATING CASH FLOW | -415.08M | -446.35M | -778.78M | 1.66B | -47.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.06M | -7.30M | -21.57M | -68.00M | -21.80M | |||
| Other Investing Activity | 604.82M | 506.67M | 186.20M | -1.13B | -119.00M | |||
| INVESTING CASH FLOW | 597.76M | 499.37M | 164.63M | -1.19B | -140.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -96.00K | -165.00K | -287.00K | -300.00K | -300.00K | |||
| Stock Issued/Repurchased | 4.93M | 4.55M | 7.77M | 36.20M | 100.60M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -1.20M | 0.00 | |||
| FINANCING CASH FLOW | 4.83M | 4.39M | 7.48M | 34.80M | 100.30M | |||
| CHANGE IN CASH | 187.52M | 57.40M | -606.68M | 504.60M | -88.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -415.08M | -446.35M | -778.78M | 1.66B | -47.60M | |||
| Capital Expenditure | -7.06M | -7.30M | -21.57M | -68.00M | -21.80M | |||
| FREE CASH FLOW | -422.14M | -453.65M | -800.36M | 1.60B | -69.40M | |||
All data in USD